Indication

Bacterial endocarditis

Bacterial endocarditis is an invasive infection and inflammation of the endocardium, most frequently involving native or prosthetic heart valves, mural endocardium, or implanted intracardiac devices. Read more about Bacterial endocarditis

119 drugs 60 manufacturers

Advertisement

Drugs that treat it

Common Bacterial endocarditis therapies.

Showing 28–36 of 119 drugs

Filter & compare in the drug finder →Opens the drug finder with Bacterial endocarditis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Bacterial endocarditis.

Bacterial endocarditis is an invasive infection and inflammation of the endocardium, most frequently involving native or prosthetic heart valves, mural endocardium, or implanted intracardiac devices.

It primarily affects the cardiovascular system, with heightened vulnerability among individuals with preexisting valvular disease, congenital cardiac anomalies, prosthetic materials, or history of intravenous drug use.

Pathophysiologically, circulating bacteria—predominantly staphylococci, streptococci, or enterococci—colonize damaged endocardial surfaces or thrombi, forming infected vegetations composed of fibrin, platelets, and microorganisms.

This process leads to progressive tissue destruction, acute or subacute valvular dysfunction, sustained bacteremia, and a high risk of life-threatening systemic embolization.

Personalize your experience

Follow Bacterial endocarditis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it